In an opinion article for Chemistry World, Darren Smyth joins five other international experts on the subject in giving his view on whether compulsory licences for patent-protected drugs are a necessary measure, or a threat to innovation.
In an opinion article for Chemistry World, Darren Smyth joins five other international experts on the subject in giving his view on whether compulsory licences for patent-protected drugs are a necessary measure, or a threat to innovation.